Category: Pharma Cash To Congress

KHN’s ‘What the Health?’: Drug Price Bill Is a Go in the Senate

Two things happened in Washington this week that were inevitable: President Joe Biden tested positive for covid-19, and the Senate agreed to move forward on a budget bill that includes only a sliver of what Biden hoped it would. Still, the bill to allow Medicare to negotiate some drug prices, cap out-of-pocket drug costs for seniors, and extend temporary subsidies for Affordable Care Act insurance premiums would represent a major step if Democrats can get it across the finish line. Meanwhile, abortion battles continue to escalate around the country, with Texas leading the way in restrictions. Shefali Luthra of The 19th, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. Jack Resneck Jr., the new president of the American Medical Association.

Big Pharma Is Betting on Bigger Political Ambitions From Sen. Tim Scott

The South Carolina senator led the congressional pack in pharma campaign contributions for the second half of 2021. There are clear reasons.

Senators Who Led Pharma-Friendly Patent Reform Also Prime Targets For Pharma Cash

Three senators on a revived subcommittee received more than $100,000 each from drugmakers.

Congress Rakes In Millions From Drugmakers

In the first six months of this year, pharmaceutical firms and their trade groups donated almost $4 million to the campaigns of a variety of senators and House members.